The novel therapeutic approach of abatacept, a T-cell modulator, and a CTLA4 immunoglobulin (CTLA4lg) represents a promising strategy for managing inflammatory conditions. This unique method intends to augment immune tolerance by blocking co-stimulatory interactions vital for T-cell activation. P